Latest Genentech Stories
INCLINE VILLAGE, Nev., June 10, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
Roche/Genentech's Avastin Continues to Garner the Greatest Physician-Reported Patient Share in DME Due to Its Low Relative Cost, According to Findings from Decision Resources Group BURLINGTON,
Ultimate Award Recipient Rackspace and Finalists including Cisco, ConAgra Foods, Genentech and Tata Consultancy Services focus on programs to acquire, grow and retain employees, manage change, and
--PDL's Revolutionary Antibody Technology Provided Basis for Eight Successful Drugs Currently on the Market-- INCLINE VILLAGE, Nev., May 6, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
Reduction in Exacerbations Remains the Top Driver of Physician Prescribing Choice in Moderate to Severe Asthma, According to Findings from Decision Resources Group BURLINGTON, Mass., May 1,
Improved Overall Survival and Delayed Disease Progression are the Greatest Unmet Needs in this Population, According to Findings from Decision Resources Group BURLINGTON, Mass., April 10, 2014
NEW YORK, April 2, 2014 /PRNewswire-iReach/ -- A mobile application focusing on rheumatoid arthritis management -- created by DKBmed, LLC, in collaboration with Clifton O.
LONDON, March 27, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
VANCOUVER, British Columbia, March 26, 2014 /PRNewswire/ -- Xenon Pharmaceuticals Inc.
- Large; stout; burly.